Amprion, Inc. — Form D
Amprion, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-07-15. The offering totals $11.0M, of which $11.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-07-15
- Form: D
- Accession: 0001937140-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $11.0M
- Amount sold: $11.0M
- Investors: 9
- Date of first sale: 2022-06-24
- Security types: equity
- Revenue range: $1,000,001 - $5,000,000
- SEC file number: 021-452680
Issuer
- Name: Amprion, Inc.
- CIK: 0001937140
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 149 NEW MONTGOMERY STREET, 4TH FLOOR, SAN FRANCISCO, CA, 94105
- Phone: 281-802-4776
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Peter Clinton | Director | San Francisco, CA |
| Kenneth Lehman | Director | Cambridge, MA |
| Claudio Soto | Director | Houston, TX |
| Marc Chan | Director | Hong Kong, K3 |
| Russell Lebovitz | Director | San Diego, CA |
| Russell Lebovitz | Executive Officer | San Diego, CA |
| Rahul Bhansali | Director | Topsfield, MA |
Other filings by this issuer (2)
More